Action of naloxone on gender-dependent analgesic and antianalgesic effects of nalbuphine in humans****

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Journal of Pain

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1526-5900(00)90097-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain.

  1999cited by this paper
• Dynorphin A increases substance P release from trigeminal primary afferent C-fibers.

  1999cited by this paper
• Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.

  1999cited by this paper
• kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.

  1998cited by this paper
• Sex differences in N-methyl-D-aspartate involvement in kappa opioid and non-opioid predator-induced analgesia in mice.

  1997cited by this paper
• Spinally administered dynorphin A produces long‐lasting allodynia: involvement of NMDA but not opioid receptors

  1997cited by this paper
• Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor

  1997cited by this paper
• Estrogen and progesterone activate spinal kappa‐opiate receptor analgesic mechanisms

  1996cited by this paper
• Gender difference in analgesic response to the kappa-opioid pentazocine.

  1996cited by this paper
• Opioid analgesics and antagonists

  1996cited by this paper
• Kappa–opioids produce significantly greater analgesia in women than in men

  1996cited by this paper
• Kappa opioid receptors participate in nerve growth factor-induced hyperalgesia.

  1995cited by this paper
• Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the κ2 receptor in guinea pig brain

  1995cited by this paper
• Enhancement of morphine analgesia by the GABAB agonist baclofen.

  1995cited by this paper
• Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice.

  1994cited by this paper
• Differences in postoperative pain severity among four ethnic groups.

  1994cited by this paper
• The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration.

  1993cited by this paper
• Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.

  1993cited by this paper
• A review of the role of anti‐opioid peptides in morphine tolerance and dependence

  1992cited by this paper
• Computer modeling of subtypes of κ opioid receptors in adrenal medulla

  1990cited by this paper
• Spinal dynorphin A (1-17): possible mediator of antianalgesic action.

  1990cited by this paper
• Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.

  1990cited by this paper
• Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).

  1989cited by this paper
• A study of the analgesic interaction between intrathecal morphine and subcutaneous nalbuphine in the rat.

  1989cited by this paper
• Potentiation of pentazocine analgesia by low-dose naloxone.

  1988cited by this paper
• Spinal κ-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a κ-selective antagonist

  1988cited by this paper
• Spinal cord mediation of the opioid analgesia of pregnancy.

  1987cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics

  1986cited by this paper
• Influence of the method of drug administration on analgesic response

  1984cited by this paper

• Negative modulation of spinal κ-opioid receptor-mediated antinociception by the µ-opioid receptor at selective doses of (−)-pentazocine

  2018cites this paper
• "GENDER DIFFERENCES IN RECOVERY TIMES FROM GENERAL ANESTHESIA USING SEVOFLURANE AND THE BISPECTRAL INDEX MONITOR"

  2018cites this paper
• PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivo.

  2016cites this paper
• Estrogen facilitates and the kappa and mu opioid receptors mediate antinociception produced by intrathecal (-)-pentazocine in female rats.

  2016cites this paper
• NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.

  2014cites this paper
• Pain Facilitation Brain Regions Activated by Nalbuphine Are Revealed by Pharmacological fMRI

  2013influential citation
• Suspected opioid overdose case resolved by CYP2D6 genotyping.

  2012cites this paper
• Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors.

  2012cites this paper
• Potentiation of buprenorphine antinociception with ultra‐low dose naltrexone in healthy subjects

  2011cites this paper
• Sex differences in kappa opioid pharmacology.

  2011influential citation
• Spinal Synthesis of Estrogen and Concomitant Signaling by Membrane Estrogen Receptors Regulate Spinal κ- and μ-Opioid Receptor Heterodimerization and Female-Specific Spinal Morphine Antinociception

  2011cites this paper
• Sex and gender differences in pain and analgesia.

  2010cites this paper
• A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative pain

  2008influential citation
• Enhanced Buprenorphine Analgesia with the Addition of Ultra‐low‐dose Naloxone in Healthy Subjects

  2008cites this paper
• A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain.

  2008cites this paper
• Open-label exploration of an intravenous nalbuphine and naloxone mixture as an analgesic agent following gynecologic surgery.

  2007cites this paper
• Neuroleptics antagonize nalbuphine antianalgesia.

  2006cites this paper
• Characterization of the antinociceptive effect of oxycodone in male and female rats.

  2006cites this paper
• Sex differences in opioid analgesia: clinical and experimental findings

  2004cites this paper
• Interactions of "ultra-low" doses of naltrexone and morphine in mature and young male and female rats.

  2004influential citation
• Sex differences in pain and analgesia: the role of gonadal hormones

  2004influential citation
• Kappa opioid receptors in rat spinal cord: sex-linked distribution differences.

  2004cites this paper
• Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats

  2003cites this paper
• Sexual dimorphism in very low dose nalbuphine postoperative analgesia.

  2003cites this paper
• Absence of nalbuphine anti-analgesia in the rat.

  2003cites this paper
• The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans

  2003cites this paper
• Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humans.

  2003cites this paper
• Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.

  2003cites this paper
• Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.

  2003cites this paper
• Sex Differences in Opioid Analgesia: “From Mouse to Man”

  2003cites this paper
• Sex differences in opioid antinociception in rhesus monkeys: antagonism of fentanyl and U50,488 by quadazocine.

  2002cites this paper
• Procede de traitement de la douleur en utilisant la nalbuphine et des antagonistes opioides

  2001cites this paper
• Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence.

  2001cites this paper
• Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.

  2001cites this paper
• Gender-specific responses reveal untapped potential of κ-opioids

  2000cites this paper
• Sex differences in opioid analgesia

  1999cites this paper